|Functional recovery in parkinsonian monkeys treated with GDNF|
DM Gash, Z Zhang, A Ovadia, WA Cass, A Yi, L Simmerman, D Russell, ...
Nature 380 (6571), 252-255, 1996
|Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line—derived neurotrophic factor|
JT Slevin, GA Gerhardt, CD Smith, DM Gash, R Kryscio, B Young
Journal of neurosurgery 102 (2), 216-222, 2005
|GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo|
CM Kearns, DM Gash
Brain research 672 (1-2), 104-111, 1995
|Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers|
MC Bohn, L Cupit, F Marciano, DM Gash
Science 237 (4817), 913-916, 1987
|Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease|
N Maswood, J Young, E Tilmont, Z Zhang, DM Gash, GA Gerhardt, ...
Proceedings of the National Academy of Sciences 101 (52), 18171-18176, 2004
|Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys|
R Grondin, Z Zhang, A Yi, WA Cass, N Maswood, AH Andersen, ...
Brain 125 (10), 2191-2201, 2002
|The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine‐depleted rats and MPTP‐treated monkeys|
T Klockgether, L Turski, T Honoré, Z Zhang, DM Gash, R Kurlan, ...
Annals of Neurology: Official Journal of the American Neurological …, 1991
|Principal component analysis of the dynamic response measured by fMRI: a generalized linear systems framework|
AH Andersen, DM Gash, MJ Avison
Magnetic resonance imaging 17 (6), 795-815, 1999
|Critical decline in fine motor hand movements in human aging|
CD Smith, GH Umberger, EL Manning, JT Slevin, DR Wekstein, ...
Neurology 53 (7), 1458-1458, 1999
|Point source concentration of GDNF may explain failure of phase II clinical trial|
MF Salvatore, Y Ai, B Fischer, AM Zhang, RC Grondin, Z Zhang, ...
Experimental neurology 202 (2), 497-505, 2006
|Functional development of grafted vasopressin neurons|
D Gash, JR Sladek Jr, CD Sladek
Science 210 (4476), 1367-1369, 1980
|Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity|
DM Gash, K Rutland, NL Hudson, PG Sullivan, G Bing, WA Cass, ...
Annals of neurology 63 (2), 184-192, 2008
|Neuroprotective and neurorestorative properties of GDNF|
DM Gash, Z Zhang, G Gerhardt
Annals of neurology 44 (S1 1), S121-S125, 1998
|Disruption of the blood-brain barrier as the primary effect of CNS irradiation|
P Rubin, DM Gash, JT Hansen, DF Nelson, JP Williams
Radiotherapy and Oncology 31 (1), 51-60, 1994
|Nerve growth factor receptor immunoreactivity in the nonhuman primate (Cebus apella): distribution, morphology, and colocalization with cholinergic enzymes|
JH Kordower, RT Bartus, M Bothwell, G Schatteman, DM Gash
Journal of Comparative Neurology 277 (4), 465-486, 1988
|Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease|
JT Greenamyre, RV Eller, Z Zhang, A Ovadia, R Kurlan, DM Gash
Annals of neurology 35 (6), 655-661, 1994
|Unilateral intraputamenal glial cell line–derived neurotrophic factor in patients with Parkinson disease: Response to 1 year of treatment and 1 year of withdrawal|
JT Slevin, DM Gash, CD Smith, GA Gerhardt, R Kryscio, H Chebrolu, ...
Journal of neurosurgery 106 (4), 614-620, 2007
|Adrenal medullary autografts into the basal ganglia of Cebus monkeys: injury-induced regeneration|
MS Fiandaca, JH Kordower, JT Hansen, SS Jiao, DM Gash
Experimental neurology 102 (1), 76-91, 1988
|Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects|
Y Ai, W Markesbery, Z Zhang, R Grondin, D Elseberry, GA Gerhardt, ...
Journal of Comparative Neurology 461 (2), 250-261, 2003
|Dose response to intraventricular glial cell line-derived neurotrophic factor administration in parkinsonian monkeys|
Z Zhang, Y Miyoshi, PA Lapchak, F Collins, D Hilt, C Lebel, R Kryscio, ...
Journal of Pharmacology and Experimental Therapeutics 282 (3), 1396-1401, 1997